Sammanfattning
BACKGROUND The prevalence of chronic non-malignant pain in Norway is between 24 % and 30 %. The proportion of the population using opioids for non-malignant pain on a long-term basis is around 1 %. The purpose of our study was to investigate how many were prescribed analgesics on reimbursable prescription under reimbursement code -71 (chronic non-malignant pain) in 2009 and 2010, which analgesics were prescribed and whether prescribing practices were in accordance with national guidelines.
MATERIAL AND METHOD We retrieved pseudonymised data from the National Prescription Database on all those who received drugs with reimbursement code -71 in 2009 and 2010. The data contain information on drug, dosage, formulation, reimbursement code and date of issue.
RESULTS 90 731 patients received reimbursement for drugs indicated for chronic non-malignant pain in 2010. Of these, 6 875 were given opioids, 33 242 received paracetamol, 25 865 non-steroid inflammatory drugs (NSAIDs), 20 654 amitryptiline and 16 507 gabapentin. Oxycodone was the most frequently prescribed opioid, followed by buprenorphine, tramadol and codeine/paracetamol. Of those who were prescribed opioids, 4 047 (59 %) received mainly slow-release opioids, 2 631 (38 %) also received benzodiazepines and 2 418 (35 %) received benzodiazepine-like sleep medications.
CONCLUSION The number of patients who received analgesics and opioids on reimbursable prescriptions was low compared to the proportion of the population with chronic pain and the proportion using opioids long-term. 38 % of those reimbursed for opioids also used benzodiazepines, which is contrary to official Norwegian guidelines.